ICA
OrganizationRelationship Network
Event Timeline
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Reverend Moon
|
Leadership |
6
|
1 | |
|
person
Bill Clinton
|
Participant |
6
|
1 | |
|
person
Woody Allen
|
Participant |
6
|
1 | |
|
person
Clarisse Thorn
|
Contractor lecturer |
5
|
1 | |
|
person
Abdullahziz Bin Hamad Al Gosaibi
|
Chairman |
5
|
1 | |
|
organization
Citibank
|
Business associate |
5
|
1 | |
|
organization
Hologix
|
Acquirer target |
5
|
1 | |
|
person
Hologix
|
Acquirer target |
5
|
1 | |
|
person
Joseph Field
|
Founder administrator |
5
|
1 | |
|
organization
Al-Qaeda
|
Alleged financier supporter |
5
|
1 | |
|
person
Prince Turki
|
Diplomatic political |
5
|
1 | |
|
person
John Cacioppo
|
Professional affiliation |
5
|
1 | |
|
person
Ackrell Capital
|
Analyst subject |
5
|
1 | |
|
person
Ali
|
Employee |
5
|
1 | |
|
organization
Mar-Jac Poultry
|
Donor recipient |
5
|
1 | |
|
organization
Trump Korea LLC
|
Business associate |
5
|
1 | |
|
person
BofA Merrill Lynch
|
Family |
5
|
1 | |
|
person
Kelvin Long
|
Co founder |
5
|
1 | |
|
person
Jeb Bush
|
Unknown |
5
|
1 | |
|
person
Ehud Barak
|
Diplomatic |
5
|
1 | |
|
organization
DJT Holdings LLC
|
Ownership |
5
|
1 | |
|
organization
401 MEZZ VENTURE LLC
|
Ownership |
5
|
1 | |
|
organization
MLPF&S
|
Affiliate subsidiary |
5
|
1 | |
|
organization
k12
|
Contractual management |
5
|
1 | |
|
person
Rudolph E. Tanzi
|
Employment |
5
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 1968-10-28 | N/A | Original filing of the Certificate of Incorporation. | Dover, Delaware | View |
| 0021-08-01 | N/A | Announcement by British and American armed forces | Iraq | View |
HOUSE_OVERSIGHT_024888.jpg
This document is page 72 of a Cowen Collaborative Insights report dated February 25, 2019, stamped with a House Oversight Bates number. It details a partnership between Authentic Brands Group (ABG) and Tilray focused on CBD wellness products, mentioning brands like Muhammad Ali and Nine West. It also features a diagram regarding Devan Chemical's CBD-infused textile technology.
HOUSE_OVERSIGHT_024877.jpg
This document is page 61 of a 'Cowen Collaborative Insights' report dated February 25, 2019, analyzing private companies in the CBD/hemp industry (Botanica, GenCanna, Highline Wellness, Lazarus Naturals, Lord Jones, and Mary's). While stamped 'HOUSE_OVERSIGHT_024877', indicating it is part of a larger document production (likely related to financial oversight), the page content itself is purely market research and contains no direct references to Jeffrey Epstein or his associates. The sidebar indicates the report was intended for Michael Cella at Cowen.
HOUSE_OVERSIGHT_024862.jpg
This document is page 46 of a market research report produced by Cowen Collaborative Insights on February 25, 2019. It analyzes the pricing segments of CBD body lotions and bath bombs, listing various brands like Mary's Nutritionals and Lord Jones. While the content is purely financial market analysis, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024862', indicating it was part of a document production for a House Oversight Committee investigation (likely related to financial records subpoenaed in the Epstein/Deutsche Bank probe), though the page itself contains no direct references to Epstein.
HOUSE_OVERSIGHT_024835.jpg
This document is page 19 of a Cowen 'Collaborative Insights' report dated February 25, 2019. It details the industry landscape for synthetic biology cannabinoid production, listing specific companies such as Ginkgo Bioworks and Amyris with brief descriptions of their technologies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, though no direct mention of Jeffrey Epstein appears on this specific page.
HOUSE_OVERSIGHT_024815.jpg
This document is a page from an Ackrell Capital report listing the 'Top 100 Private Cannabis Companies 2018'. It contains a categorized list of 100 entities in the cannabis industry, a standard investment disclaimer footer, and a Bates stamp indicating it is part of a House Oversight Committee investigation (HOUSE_OVERSIGHT_024815). No specific individuals, aircraft, or direct communications are listed on this page.
HOUSE_OVERSIGHT_024814.jpg
A 2018 market landscape chart titled 'The Green Field 2018' produced by Ackrell Capital. The document categorizes hundreds of cannabis industry companies into sectors such as Consumer Products (Flower, Infused), Vaporizers, Pharmaceuticals, Business Solutions (Software, Services), and Digital Media. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation or subpoena.
HOUSE_OVERSIGHT_024780.jpg
This document is page 144 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It contains company profiles for four businesses in the cannabis industry: Confident Cannabis, Cultivation Technologies, Cura Cannabis Solutions, and CW Analytical. The document bears a House Oversight Bates stamp number 024780.
HOUSE_OVERSIGHT_024775.jpg
This document is page 139 of an Ackrell Capital investment report titled 'Chapter VIII Top 100 Private Cannabis Companies 2018'. It provides company profiles for AEssenseGrows, Ample Organics, Apeks Supercritical, and The Apothecarium, detailing their locations, websites, and business descriptions. The document bears the Bates stamp HOUSE_OVERSIGHT_024775, indicating it was part of a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024774.jpg
This document is page 138 from a December 2017 Cannabis Investment Report produced by Ackrell Capital. It lists the 'Top 100 Private Cannabis Companies' for 2018, categorized alphabetically across four columns. The document bears a 'HOUSE_OVERSIGHT_024774' stamp, indicating it is part of a House Oversight Committee investigation file.
HOUSE_OVERSIGHT_024770.jpg
This document is page 134 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital, LLC. It contains data visualizations and tables detailing capital raised by private cannabis-related companies globally in 2016 and 2017, listing specific financings for companies like düber Technologies and Eaze Solutions. The document bears a 'HOUSE_OVERSIGHT_024770' Bates stamp, indicating it was part of a document production to the House Oversight Committee, likely related to investigations into financial institutions connected to Jeffrey Epstein, though Epstein himself is not mentioned on this specific page.
HOUSE_OVERSIGHT_024767.jpg
This document is page 131 of a report by Ackrell Capital titled 'Chapter VII Capital Markets for Cannabis Companies.' It presents a detailed financial table of companies listed on the Canadian Securities Exchange as of November 30, 2017. The table includes stock prices, market values, enterprise values, revenue, and EBITDA multiples for numerous cannabis-related entities. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024767', indicating it was part of a production to the House Oversight Committee.
HOUSE_OVERSIGHT_024761.jpg
This document is Page 125 of a financial report produced by Ackrell Capital, LLC, titled 'Chapter VII Capital Markets for Cannabis Companies.' It contains a data table listing 'Over The Counter' cannabis stocks with market values greater than $25 million as of November 30, 2017. The table provides financial metrics such as stock price, market value, enterprise value, and revenue for numerous entities. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024761', indicating it was part of a document production to the House Oversight Committee, likely related to investigations into financial records.
HOUSE_OVERSIGHT_024759.jpg
This document is page 123 of a report by Ackrell Capital regarding capital markets for cannabis companies, bearing a House Oversight Bates stamp. It presents statistical data on capital raised by U.S. publicly traded cannabis companies for the twelve months ending September 30, 2017, breaking down amounts by exchange (Nasdaq, NYSE, OTC). While part of a document production likely related to broader financial investigations (possibly involving banks linked to Epstein), this specific page contains no direct references to Jeffrey Epstein or his associates.
HOUSE_OVERSIGHT_024757.jpg
This page from an Ackrell Capital report details capital raised by publicly traded cannabis companies for the year ending September 30, 2017, highlighting that Canadian companies raised significantly more capital than those in the U.S. or Australia. It also provides an overview of the U.S. public capital markets for cannabis, noting that while a few trade on major exchanges like Nasdaq and NYSE, the vast majority are "penny" stocks on the OTC market characterized by high risk and regulatory scrutiny from the SEC and FINRA.
HOUSE_OVERSIGHT_024736.jpg
This page from a 2017 Ackrell Capital Cannabis Investment Report details the legal status and recent developments regarding medical cannabis in Greece, the United Kingdom, and regions across the Middle East, Asia, and Africa. It highlights specific legislative changes in South Africa and Lesotho, as well as Israel's established medical cannabis program and its 2017 move to allow exports.
HOUSE_OVERSIGHT_024218.jpg
This document is page 17 of a confidential 'Global Utility White Paper' produced by Electron Capital Partners, LLC, specifically marked for the exclusive use of Jeffrey Epstein. It analyzes historical trends in the utility sector, citing Warren Buffett's investments and market behavior during the dotcom bust, while also drawing parallels to Japan's economic history. The document is part of a larger collection obtained by the House Oversight Committee.
HOUSE_OVERSIGHT_024184.jpg
This document is an itinerary for 'HEP' (likely the President of the Maldives, indicated by the national emblem) covering a trip to the Los Angeles area from September 29 to October 5, 2012. The schedule details arrival via American Airlines, a dinner hosted by 'Navarro,' a multi-day leisure trip to Catalina Island and Disneyland, and departure via Emirates. The document bears a House Oversight Committee Bates stamp, suggesting it is part of a congressional investigation.
HOUSE_OVERSIGHT_024128.jpg
This document appears to be page 22 of a report by the consulting firm Protiviti, prepared for the House Oversight Committee (indicated by the Bates stamp HOUSE_OVERSIGHT_024128). The text outlines historical regulatory failures regarding Anti-Money Laundering (AML) and the Bank Secrecy Act (BSA) at HSBC and Citibank. It details Cease and Desist orders issued by the Federal Reserve and the OCC in 2010 and 2012, citing deficiencies in monitoring suspicious activity, wire transfers, and foreign correspondent banking. While part of an investigation file often associated with Epstein (likely the Deutsche Bank investigation), this specific page focuses on the regulatory history of other major banks as context.
HOUSE_OVERSIGHT_024109.jpg
This document page contains footnotes (C through G) for a financial report, detailing the methodology used to calculate investment returns (IRR, DPI) for 'Sprout Funds' and funds identified as 'NLV-I' and 'NLV-II'. It establishes a valuation date of March 31, 2014, defines healthcare technology sectors, and references data provided by Cambridge Associates for benchmarking. The document bears a House Oversight Committee Bates stamp.
HOUSE_OVERSIGHT_024104.jpg
This document is a confidential financial schedule detailing the 'Healthcare Technology Portfolio' performance for two funds: Sprout Capital VII, L.P. and Sprout Growth II, L.P., as of March 31, 2014. It lists specific portfolio companies (such as WebMD, Cephalon, and Adeza Biomedical), the vintage year of investment (ranging 1994-2003), investment costs, realized values, and Internal Rates of Return (IRR). The document bears a House Oversight Bates stamp (HOUSE_OVERSIGHT_024104), indicating it was part of a congressional investigation, likely related to financial probes involving entities connected to the broader Epstein investigation.
HOUSE_OVERSIGHT_024103.jpg
This document is a financial appendix page (marked CONFIDENTIAL) bearing a House Oversight Bates stamp (HOUSE_OVERSIGHT_024103). It details the investment performance of 'Sprout Capital VIII, L.P. (Healthcare Technology Portfolio)' as of March 31, 2014. It lists specific investments in healthcare and technology companies (such as Charles River Laboratories and eHealth, Inc.), showing the vintage year (ranging from 1998-2000), total cost, realized value, and internal rate of return (IRR) for each.
HOUSE_OVERSIGHT_024102.jpg
This document is a confidential financial schedule for 'Sprout Capital IX, L.P. (Healthcare Technology Portfolio)' as of March 31, 2014. It details realized and unrealized investments in numerous healthcare and biotechnology companies, listing vintage years, costs, realized values, and IRRs. The document bears a 'HOUSE_OVERSIGHT' footer, indicating it was part of a congressional investigation.
HOUSE_OVERSIGHT_024100.jpg
This document is a confidential financial appendix (Appendix 1) labeled 'Listing of Investments by Fund' for New Leaf Ventures II, L.P., dated March 31, 2014. It details the financial performance of numerous healthcare, therapeutic, and diagnostic companies in the fund's portfolio, split into realized/partially realized and unrealized investments. The document bears a House Oversight Committee stamp and a confidential control number, indicating it is part of a congressional investigation.
HOUSE_OVERSIGHT_029954.jpg
This document is page 23 of a file marked with the Bates stamp HOUSE_OVERSIGHT_029954. It contains a Scientific American article excerpt dated July 2, 2011, written by David Linden, titled 'How the Brain Understands Food and Appetite.' The text discusses the biological mechanisms of energy expenditure, caloric intake, and homeostasis in mammals.
HOUSE_OVERSIGHT_029931.jpg
This document is a scanned page from the December 12, 2011 issue of The New Yorker (page 36), bearing a 'HOUSE_OVERSIGHT' Bates stamp. It contains a profile of Harvard Medical School professor Ted Kaptchuk, detailing his unconventional background, his NIH-funded research into the placebo effect, and the author's own experience with medical reassurance acting as a placebo. While the document is part of a House Oversight production (possibly related to investigations into scientific funding or associations), the text itself does not mention Jeffrey Epstein.
| Date | Type | From | To | Amount | Description | Actions |
|---|---|---|---|---|---|---|
| N/A | Paid | ICA | Andrea Constand | $20,000.00 | Payment resulting from an interview Cosby gave ... | View |
| 2018-10-10 | Paid | ICA | Egypt and state-o... | $150,000,000.00 | Settlement deal to resolve arbitrations. | View |
| 2018-01-01 | Paid | ICA | DONALD J. TRUMP | $110,713.00 | Management fees | View |
| 2018-01-01 | Paid | ICA | DONALD J. TRUMP | $101,487.00 | Management fees | View |
| 2018-01-01 | Paid | ICA | DONALD J. TRUMP | $524,819.00 | Management fees | View |
| 2018-01-01 | Paid | ICA | DONALD J. TRUMP | $110,713.00 | Management fees | View |
| 2018-01-01 | Paid | ICA | DONALD J. TRUMP | $101,487.00 | Management fees | View |
| 2017-06-01 | Received | Unknown Investors | ICA | $5,900,000.00 | Financing/Capital Raise | View |
| 2002-12-07 | Paid | ICA | Unknown (Implied ... | $5,000.00 | Utility service donation | View |
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity